Demand cluster · "GLP-1 · month-3 adherence drop" PATIENT SIGNAL · SP 0.92
3,217+184%
Patients / 7d
0.92
Signal score
−0.52
Net sentiment
8+4
Side-effect themes
Cohort breakdown
primary
adjacent
Listen across patient communities, providers and payers. Quantify lived experience around therapies, diagnostics and aftercare — with structure that survives clinical and commercial review.
Every dot is a friction patients are actively hacking around — peer-built tapering guides, DIY discharge plans, off-label workarounds. The bottom-right quadrant is what your therapy doesn't formally support against behaviour that's already mainstream. That gap is your next patient program, RWE study, or digital health bet.
Patient communities hold richer signal on adherence and side effects than most RWE pipelines.
How clinicians actually talk about a therapy precedes formal adoption or pushback.
Coverage decisions are reverse-engineered too late from claims data.
Continuous read on lived experience by condition, therapy and cohort — adherence, side effects, switching.
How clinicians actually discuss a therapy across forums, conferences and professional networks.
Identify where in the patient journey adherence breaks — and the specific friction driving it.
We'll show you a live read against your category. 30 minutes, no fluff.